Production of radiopharmaceuticals
Photo: Alexander Ryumin/TASS
Promotion in Russia and abroad of nuclear technologies for medicine will instruct subsidiary of the Corporation entitled Rusatom Healthcare
The state Corporation “Rosatom” will create a new company Rusatom Healthcare (JSC “RusAtom, Chelsea”), which will promote to the world market of Russian developments in the field of nuclear medicine and implementation of advanced technologies in Russia, RBC reported close to the “Rosatom” source.
According to him, 100% of the shares Rusatom Healthcare will belong to “Atomenergoprom” (“daughter” of “Rosatom”). Currently Atomenergoprom already owns the United innovation Corporation (OIC), which, in particular, offers a partnership in the establishment of departments and centres in the field of medical radiation technology.
Rusatom Healthcare will have to deal with is not individual medical centers, and development of all activities of Rosatom and its subsidiaries in the field of nuclear medicine under a single brand. In the area of its responsibility will be, and radiopharmaceuticals, and isotope production for medicine and the creation of centres of radiation and sterilization and production equipment for them, both diagnostic and therapeutic.
The company also plans to develop new technologies and localize the production of equipment based on Western technology.
“The company will work on the Russian market and foreign countries. First and foremost it is the country that already have a strong presence of “Rosatom”, — said the interlocutor of RBC.
According to Rosatom, more than 50% of all radioactive isotopes are accumulating in our days in the world, used for medical purposes.
In October 2015, the Russian government approved the “road map” of development of nuclear medicine centres, providing improved accessibility and improving the quality of diagnosis and treatment of diseases using nuclear medicine.
In early 2016, the Deputy Minister of industry and trade of the Russian Federation Sergey Tsyb assured that nuclear medicine in Russia will not suffer due to the difficult economic situation.